Sort
16,300 grants matching “fatty liver disease”
Center for Alzheimer's and Related Dementias (CARD): Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias Community
$28,171,195Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG
Epidemiology of Diabetes Interventions and Complications (EDIC) Study
$7,999,999Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2024 · DK
REPRIEVE - CCC - Lead Application
$7,726,001Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2019 · HL
Epidemiology of Diabetes Interventions and Complications (EDIC) Study
$7,716,293Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2025 · DK
Epidemiology of Diabetes Interventions and Complications (EDIC) Study
$7,700,000Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2023 · DK
NIAAA Repository/Screening Database Management and Research
$7,238,358Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA
Advanced Non Invasive Vascular Imaging Methods
$7,009,057Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Advanced Non Invasive Vascular Imaging Methods
$6,769,984Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation
$6,700,000Christine Marie Durand · Johns Hopkins University · U01 · FY2023 · AI
1/2 REPRIEVE Extension for Trial Completion
$6,567,877Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2023 · HL
Epidemiology of Diabetes Interventions and Complications (EDIC) Study
$6,499,998Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2022 · DK
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,064,830Keri, Hammel · The Emmes Company, Llc · N01 · FY2013 · EY
REPRIEVE - CCC - Lead Application
$6,060,885Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2014 · HL
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,059,050Keri Hammel · The Emmes Company, Llc · N01 · FY2014 · EY
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic
$6,032,754Jeffrey S Glenn · Stanford University · U19 · FY2017 · AI
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic
$6,002,828Jeffrey S Glenn · Stanford University · U19 · FY2016 · AI
Integrative genetics of behavior with high throughput technologies
$5,808,197David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Neurobiology of Substance Abuse and Addiction
$5,706,736Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Southern California Center for Chronic Health Disparities in Latino Children and Families.
$5,655,066Michael I Goran · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD
Integrative genetics of behavior with high throughput technologies
$5,648,001David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Integrative genetics of behavior with high throughput technologies
$5,607,530David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Advanced Non Invasive Vascular Imaging Methods
$5,552,555Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic
$5,480,207Jeffrey S Glenn · Stanford University · U19 · FY2018 · AI
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic
$5,471,076Jeffrey S Glenn · Stanford University · U19 · FY2015 · AI
Molecular Basis of Cholesterol Metabolism
$5,439,491Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2009 · HL